Explore By Subject Area   
Return Home
Menu

Lead Editorial

How AstraZeneca’s Lead Human Factors Engineer is Improving Drug Device User Experience by Integrating Patient Input

How AstraZeneca’s Lead Human Factors Engineer is Improving Drug Device User Experience by Integrating Patient Input

AstraZeneca’s Lead Human Factors Engineer, Kayley Wolf Raskin, discusses her own experience as a diabetes patient engaging with combination devices and how companies can derisk device development by prioritizing patient experience.

Read More

Featured Editorial

How Genentech Makes Device Decisions to De-Risk Combination Product Development

Read More

Novel Approaches to Achieve Long-Acting Formulations for Biologics

Read More

Investing in More Engaging Connected Devices to Improve Patient Outcomes

Read More

Working with Outsourcers to Get Combination Products to Market Faster

Sponsored

Read More

More Related Content

Editorial

PODD 2023: The Future of Digital Technology in the Connected Device Space

PODD 2023: The Future of Digital Technology in the Connected Device Space
New Processes Enabling the Development and Commercialization of Long-Acting Injectables

New Processes Enabling the Development and Commercialization of Long-Acting Injectables

Sponsored
Partnering Advice from the Eli Lilly Genetic Medicines Search & Evaluate Team Lead

Partnering Advice from the Eli Lilly Genetic Medicines Search & Evaluate Team Lead
Bringing the User Experience to Drug Delivery Devices – An Untapped Opportunity For Pharma

Bringing the User Experience to Drug Delivery Devices – An Untapped Opportunity For Pharma

Sponsored
Exosome Delivery: The Past and Future

Exosome Delivery: The Past and Future
How Chiesi Evaluates Cell & Gene Delivery Technologies

How Chiesi Evaluates Cell & Gene Delivery Technologies
How Pfizer is Improving Lipid Nanoparticle Delivery of Complex Therapies

How Pfizer is Improving Lipid Nanoparticle Delivery of Complex Therapies
How AstraZeneca is Solving Delivery Challenges for mRNA Therapies

How AstraZeneca is Solving Delivery Challenges for mRNA Therapies
Developing a Novel Oral Monoclonal Antibody

Developing a Novel Oral Monoclonal Antibody
Product Drug Delivery Optimization for More Choices in Flexible Care Settings with Roche

Product Drug Delivery Optimization for More Choices in Flexible Care Settings with Roche
Drug Delivery Patient Perspective on Self-Injection, Plus Areas for Improvement

Drug Delivery Patient Perspective on Self-Injection, Plus Areas for Improvement
From the Langer Lab: Self-Boosting Vaccines and the Power of Collaboration

From the Langer Lab: Self-Boosting Vaccines and the Power of Collaboration
How Subcutaneous Delivery of Checkpoint Inhibitors Enabled a Remote Oncology Trial at USC

How Subcutaneous Delivery of Checkpoint Inhibitors Enabled a Remote Oncology Trial at USC
A Drug Delivery Veteran on Finding External Technologies and Forming Successful Partnerships

A Drug Delivery Veteran on Finding External Technologies and Forming Successful Partnerships
Genentech R&D VP on Optimizing Drug Delivery for a Complex Portfolio

Genentech R&D VP on Optimizing Drug Delivery for a Complex Portfolio
Biological Engineering MIT Professor on Solving Unmet Medical Needs and Increasing Gender Equity in Biotech

Biological Engineering MIT Professor on Solving Unmet Medical Needs and Increasing Gender Equity in Biotech
AstraZeneca’s Head of Advanced Drug Delivery Discusses Her Career Journey and Passion for the Industry

AstraZeneca’s Head of Advanced Drug Delivery Discusses Her Career Journey and Passion for the Industry

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.